Related references
Note: Only part of the references are listed.EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Glucocorticoid Dose Thresholds Associated With All-Cause and Cardiovascular Mortality in Rheumatoid Arthritis
Inmaculada del Rincon et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Changes in Use of Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis in the United States During 1983-2009
Seoyoung C. Kim et al.
ARTHRITIS CARE & RESEARCH (2013)
Decline of Mean Initial Prednisone Dosage From 10.3 to 3.6 mg/day to Treat Rheumatoid Arthritis Between 1980 and 2004 in One Clinical Setting, With Long-Term Effectiveness of Dosages Less Than 5 mg/day
Theodore Pincus et al.
ARTHRITIS CARE & RESEARCH (2013)
Low-Dose Prednisone Inclusion in a Methotrexate-Based, Tight Control Strategy for Early Rheumatoid Arthritis A Randomized Trial
Marije F. Bakker et al.
ANNALS OF INTERNAL MEDICINE (2012)
Trends in treatment and outcomes of rheumatoid arthritis in Germany 1997-2007: results from the National Database of the German Collaborative Arthritis Centres
Stefanie Ziegler et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Dose-related patterns of glucocorticoid-induced side effects
D. Huscher et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases
J. N. Hoes et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Diamonds are forever: the cortisone legacy
Stephen G. Hillier
JOURNAL OF ENDOCRINOLOGY (2007)
Glucocorticoids and cardiovascular events in rheumatoid arthritis - A population-based cohort study
John M. Davis et al.
ARTHRITIS AND RHEUMATISM (2007)
Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens:: current questions and tentative answers in rheumatology
F Buttgereit et al.
ANNALS OF THE RHEUMATIC DISEASES (2002)
Low-dose prednisone therapy for patients with early active rheumatoid arthritis: Clinical efficacy, disease-modifying properties, and side effects - A randomized, double-blind, placebo-controlled clinical trial
AA van Everdingen et al.
ANNALS OF INTERNAL MEDICINE (2002)
Share Paper
